Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AcSDKP-NH2 for Measuring GFR
NCT01588756Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Oct 2010
- Primary completion
- May 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2 trial of N-acetyl-seryl-aspartyl-lysyl-proline amide in chronic kidney disease (CKD) (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Glomerular Filtration Rate. Started Oct 2010; status: completed.
02
Drugs
N-acetyl-seryl-aspartyl-lysyl-proline amide
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT01588756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01588756.